▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #3309 by analyst upside · 2026-11-14
GDRX
GoodRx Holdings, Inc.
Healthcare · Market Cap $1B · P/E 71.2x
ANALYST PRICE TARGET
+11.0%
implied upside to consensus target
Current Price $3.56
Consensus Target $3.95
Bull Target $5.0
Bear Target $2.65
Analysts Covering 12
ANALYST CONSENSUS - HOLD
Strong Buy
1
Buy
3
Hold
7
Sell
1
52-Week Low $1.77
52-Week High $3.89
YTD Return +29.5%
FUNDAMENTALS
Market Cap $1B
P/E Ratio (TTM) 71.2x
Forward P/E 10.1x
EPS (TTM) $0.05
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $785M
Profit Margin 2.1%
52-WEEK RANGE
52-Week Low $1.77
52-Week High $3.89
Current Price $3.56
Bear Target $2.65
Bull Target $5.0
● Now $3.56 ● Target $3.95
TRADING DATA
Avg Volume 1.2M
YTD Return +29.5%
Analyst Count 12
Consensus Hold
Upside to Target +11.0%
Last Updated 2026-11-14

ANALYST SUMMARY

GoodRx Holdings, Inc. (GDRX) is currently trading at $3.56 with a Wall Street consensus price target of $3.95, implying potential upside of 11.0% over the next 12 months. 12 analysts currently cover GDRX, with a consensus rating of Hold - 33% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $5.0, while the most cautious has a target of $2.65.

GDRX operates in the Healthcare sector with a market capitalisation of $1B. The stock is up 29.5% year-to-date and is currently trading near the upper end of its 52-week range of $1.77 – $3.89.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for GDRX, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Barclays - Reiterated
Underweight → Underweight 2026-08-21 Building track record
UBS - Reiterated
Neutral → Neutral 2026-08-13 33% win rate (6 calls)
Citigroup - Reiterated
Buy → Buy 2026-08-11 Building track record
TD Cowen - Reiterated
Buy → Buy 2026-08-11 Building track record
Wells Fargo - Reiterated
Overweight → Overweight 2026-08-07 Building track record
Citigroup - Reiterated
Buy → Buy 2026-05-14 Building track record
TD Cowen - Reiterated
Buy → Buy 2026-05-11 Building track record
Wells Fargo - Reiterated
Overweight → Overweight 2026-03-04 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
39
out of 100
Coverage depth
20/30
Consensus clarity
17/30
Vote unanimity
0/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →